Chief Executive Officer
Lawrence Patrick serves as the Chief Executive Officer of the Imperial College London Diabetes Centre (ICLDC). In this capacity, he provides strategic leadership and direction towards achieving the Centre’s emerging growth objectives.
With 20 years of experience in healthcare, Lawrence's areas of expertise include continuous quality improvement, patient satisfaction initiatives, and facility planning and development.
Prior to joining ICLDC, he served as Managing Director for the Asia region at Johns Hopkins Medicine International, overseeing the company’s international business across the continent. He concurrently served as CEO of the Johns Hopkins Singapore International Medical Centre and Tokyo Midtown Medical Center, in Japan, a Johns Hopkins affiliate. Lawrence also managed the Johns Hopkins University Division of Biomedical Sciences.
He holds a Master’s Degree in Health Administration from the Medical College of Virginia and a Bachelor’s Degree in Economics from the University of Washington in the United States.
Consultant Physician and Endocrinologist
With a special interest in thyroid disorders and insulin treatment, Dr Saf Naqvi also has a niche specialsm in carrying out complex hormone investigations. He is a Certified General and Metabolic Physician, specialising in the management of hormone disorders. Dr Saf has a wealth of experience, gathered from a career in the UK. Having led diabetes care in hospitals and the community, he has helped develop and maintain high standards wherever he has practiced. He was appointed Medical Director and joined the Executive Team at Imperial College London Diabetes Centre in 2015.
Deputy Medical Director
Consultant Endocrinologist and Diabetologist
Dr Hawaa Al Mansouri is one of the first of a new generation of Emiratis to specialise in a career in medicine. She was awarded the prestigious Presidential Scholarship to study in the U.S in 1999 and became the first non-American woman to graduate from George Washington University School of Medicine & Health Sciences. She has extensive experience in the field of population genetics and a keen interest in linking basic science bench work to solving clinical issues, with additional, valuable experience in the care of patients at National Institutes of Health (NIH), a leading research institute. Since completing her endocrinology training in the U.S, she has become a leading figure in the regional study and practice of endocrinology and diabetes.
She is an innovator and entrepreneur, contributing not only to new schools of thought in her areas of specialism, but is also the inventor of an ultrasound-compatible FDA-approved guide wire introducer for peripheral access, the Sonostik, which will soon be in production in the United Arab Emirates. She was presented at the 2014 UAE. Government Summit by H.H. Sheikh Mansour bin Zayed Al Nahyan as an example of success in education and innovation. For her innovative efforts, she received the prestigious "Firsts in the UAE" award, granted by H.H Mohammed bin Rashid Al Maktoum. Since then she has presented and acted as Master of Ceremonies at events such as the World Government Summit.
Dr Hawaa was appointed Deputy Medical Director at Imperial College London Diabetes Centre in 2016, the region’s leading one-stop-shop for diabetes treatment, research, awareness and professional education, and focuses on lifestyle practices as an effective measurement tool for managing, preventing and even reversing diabetes for her patients at the clinic.
Director of Operations
As Director of Operations at ICLDC, Shukri Abu Ata has been overseeing the day to day running of Imperial College Diabetes Centre since its opening in 2006. A larger than life character, Shukri has embodied the patient-led approach at ICLDC, playing his part in making it a leading diabetes centre in the Gulf Region. Shukri also has a unique place in the history of ICLDC, having been part of the original construction of the Centre and later, as the Centre expanded, being a catalyst in the evolvement and further enhancement of the building and its facilities. He arrived in the UAE in the late 1980s, as a licensed pharmacist, developing his interest in diabetes. Shukri was appointed as a member to the Executive Team at Imperial College London Diabetes Centre in 2015.
Information Technology Director
As Director of Information Technology (IT) and a member of the Executive Team at Imperial College London Diabetes Centre (ICLDC), Shadi Dweik is responsible for setting and implementing the IT vision and strategy ultimately helping patients, physicians and staff experience for better outcomes through technology.
Shadi oversees ICLDC’s IT department ensuring support for clinical, operational, and administrative functions through the deployment of ICLDC’s health information system, IT infrastructure, applications portfolio, project management, and technical support services. With ICLDC from day one, Shadi has worked on large scale, strategic projects including expansion and integration initiatives involving IT infrastructure set-up across all ICLDC branches, thereby facilitating seamless coordination of patient care across all sites.
Shadi brings nearly 15 years of experience to the role including a number of years at leading regional ICT service providers, Injazat Data Systems (wholly-owned by Mubadala) and the Integrated Technology Group (ITG) in Jordan.
Director – Administration
Jaber Almehrzi serves as the Director of Administration for Imperial College London Diabetes Centre (ICLDC). In this capacity, he oversees several key functions including strategic planning and project management. He also works with senior management to define and develop strategy, innovation and expansion programmes at ICLDC and across the Mubadala Healthcare network, of which ICDLC is a member.
Prior to joining ICLDC, Mr Almehrzi worked across Mubadala Investment Company and its assets for more than 10 years. He held multiple positions in business development and operations management, focusing on Mubadala Healthcare assets.
Mr Almehrzi holds a BSc Biomedical Engineering from Marquette University (USA), and has completed level I of the Certified Financial Analysis Examination.
Nursing & Quality Director
Michelle Franklin joined the Executive Team of Imperial College of London Diabetes Centre (ICLDC) in the newly created role of Nursing Director. She will define and implement the vision and strategy for nursing and quality in all three of ICLDC centres to ensure patients have a safe, efficient, effective, and patient-centred journey through their care.
Michelle comes to ICLDC with over 30 years of nursing experience in large, for-profit, integrated health networks such as Hospital Corporation of America (HCA) and Take Care Health Systems (a subsidiary of Walgreens) in the US. She has worked locally in nursing and quality for both inpatient and outpatient clinics and hospitals. She has led extensive operational improvement projects in nursing, pharmacy, and emergency departments.
Michelle holds a Bachelor’s of Science in Nursing from the University of Illinois and a Master’s in Business Administration from The Massey Graduate School of Business, Belmont University. She is certified in Healthcare Quality and a Patient Safety Leadership Fellow.
Human Capital Director
Rahma Al Saeedi serves as Human Capital Director of Imperial College London Diabetes Centre (ICLDC). In this capacity, she enhances employee engagement and customer relationship management, maximizing productivity and profitability..
Al Saeedi has a decade of experience in human capital development. She joined ICLDC from Abu Dhabi Finance, where she was senior vice president for human resources and administration. Prior to this, she spent several years at Global Aerospace Logistics, as Head of Learning and Development.
An Emirati national, she holds a bachelor’s degree in business and management.